Haematology Diagnostics Market size worth US$2.777 billion by 2030

The haematology diagnostics market is evaluated at US$2.366 billion for the year 2025, growing at a CAGR of 3.09% to reach the market size of US$2.777 billion by the year 2030.

Haematology diagnostics refers to the diagnosis of diseases or disorders related to blood, including anaemia, blood cancer, blood clots, and infections among others by analysing the blood and its various components like RBCs, WBCs, haemoglobin etc.

• Growth Drivers in Haematology Diagnostics Market

The blood and blood-related disorders in human beings have increased over the past few decades and are increasing due to a combination of factors such as changing lifestyles, nutrition-deficient populations in many countries and ageing populations among others. For instance, as per data from the World Bank, the prevalence of anaemia among children aged 6-59 months has increased from 10.4% in 2010 to 13.2% in 2019. In Finland, it has increased from 10% in 2010 to 11.8% in 2019, while in Denmark, it reached 14.5% in 2019, rising from 12.6% in 2010. This has caused the haematology diagnostic market to propel over the years. Further, there are technological developments in the diagnostics market leading to early and accurate disease detection propelling the market steady growth of haematology diagnostics.

The haematology diagnostics market is anticipated to experience steady growth. Some companies are focusing on technological development and through partnership & collaboration trying to gain a competitive edge in the market and aiming at dominating the market. For instance, Roche, one of the key market players, in November 2024 bought the US gene therapy developer Poseida Theraupatics to augment their cell therapy capabilities.

• Segmentation of the Haematology Diagnostics Market

The haematology diagnostics market by test type is segmented into Haemoglobin, Blood Count, Platelet Function, Hematocrit and Others such as flow cytometry tests etc. The haematology diagnostics market includes tests to measure haemoglobin levels in the blood during various disease diagnoses such as anaemia. It also includes blood count of RBCs and WBCs, Haemoglobin, platelets etc. during the diagnosing of various diseases. In the forecast period, the Blood count segment will continue to dominate the haematology diagnostics market as the blood count segment has a broad application for diagnosing various diseases as blood count helps in providing insights into various components of blood.

The haematology diagnostics market by end-user is segmented into hospitals & clinics, diagnostics centers and others such as blood banks, academic research etc. The haematology market has a strong presence in the hospitals & clinics segment as blood and blood-related diagnosis is central to patient and patient care. They are major end-users of haematology diagnostic tests. Diagnostics centers are also a major end-user of haematology diagnostic tests as many patients outsource their tests and diagnosis from outside the hospitals. Also, many hospitals don’t have a broad range of haematology diagnostic tests as a diagnostics center have. Further, individuals who want routine check-up uses diagnostic center rather than hospitals. During the forecast period, diagnostic centers are anticipated to experience faster growth in the haematology diagnostics market

Based on geography, the North American region is projected to hold a significant market share during the forecast period. The better healthcare infrastructure and the high disposable income combined have fostered the establishment of numerous diagnostics centers across North American countries. This has provided a significant boost to the haematology diagnostics in the region. Also, the North American market is anticipated to witness growth in medical facilities more than before and when coupled with the high prevalence of chronic diseases in the population is causing the market for haematology diagnostics to grow.

• Key Players in the Haematology Diagnostics Market

The report includes the major players operating in the haematology diagnostics market Bio-Rad Laboratories, Inc., Boule Diagnostics AB, Abbott Laboratories, Diatron, Biosystems S.A., F. Hoffmann-La Roche Ltd, Horiba, Ltd., Erba Diagnostics Mannheim GmbH, Ortho Clinical Diagnostics and Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

View a sample of the report or purchase the complete study at: https://www.knowledge-sourcing.com/report/haematology-diagnostics-market

The market analytics report segments the haematology diagnostics market as follows:

• By Test Type
  • Hemoglobin
  • Blood Count
  • Platelet Function
  • Hematocrit
  • Others
• By End-User
  • Hospitals and Clinics
  • Diagnostic Centers
  • Others
• By Geography
  • North America
    • USA
    • Canada
    • Mexico
  • South America
    • Brazil
    • Argentina
    • Others
  • Europe
    • Germany
    • France
    • UK
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Others
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Taiwan
    • Thailand
    • Indonesia
    • Others
• Tissue Diagnostics Market Report
• Global Cancer Diagnostics Market Size
• Point of Care Diagnostic Market Size